December 19, 2011 14:00 — 0 Comments
New Drug Candidate May Halt Decline of Alzheimer’s Sufferers
A new drug candidate may be the first capable of stopping the devastating mental decline of Alzheimer’s disease, based on the results of a study recently published on www.plosone.org.
The drug, referred to as J147, improved memory and prevented brain damage caused by the disease when given to mice with Alzheimer’s. Developed by scientists at the Salk Institute for Biological Studies, the compound could be tested for treatment of the disease in humans in the near future. For more information, click here to read the full release.


Calendar/Courses
106th Meeting of the Senior Society of Neurological Surgeons
June 6-9, 2015; Miami
Neuromonitoring in Neurosurgery
European Association of Neurosurgical Societies (EANS)
June 14-16, 2015; Verona, Italy
Rocky Mountain Neurosurgical Society 50th Annual Meeting
June 20-24, 2015; Colorado Springs, Colo.
CARS 2015 - 29th International Congress and Exhibition
June 24-27, 2015; Barcelona, Spain
Neurotrauma 2015
June 28-July 01, 2015; Santa Fe, N.M.
Interactive Calendar
Advertisements